Completed
Topics
The Forum on Regenerative Medicine hosted its first public workshop with the goal of developing a broad understanding of the opportunities and challenges associated with regenerative medicine cellular therapies and related technologies. Stakeholder groups, including research scientists, clinicians, and representatives from patient groups and industry, presented their perspectives and participated in discussions during the workshop, which focused on an exploration of the state of the science of cell-based regenerative therapies within the larger context of patient care and policy.
Featured publication
Workshop
ยท2017
Regenerative medicine holds the potential to create living, functional cells and tissues that can be used to repair or replace those that have suffered potentially irreparable damage due to disease, age, traumatic injury, or genetic and congenital defects. The field of regenerative medicine is broad...
View details
Description
An ad hoc committee will plan and conduct a one-day public workshop to examine and discuss the state of the science in the field of regenerative medicine. The goal of the workshop will be to begin with an overview to set the foundation for the field, then to focus in on opportunities and challenges for future work in regenerative medicine, concentrating on understanding the underlying biology of potentially promising cellular therapies. Gathering this information will also help facilitate future Forum discussions around the issues of implementing regenerative medicine therapies and technologies, such as developing standards, examining regulatory pathways, addressing reimbursement issues, and considering bioethical matters. Discussions during this workshop will be held with a broad array of invited stakeholders which may include research scientists, clinicians, patients, payers, regulators, and representatives from pharmaceutical and biotech companies. The planning committee will develop the workshop agenda, select and invite speakers, and moderate the discussions. Proceedings from the workshop will be prepared by a designated rapporteur in accordance with institutional policies and procedures.
Collaborators
Committee
Cindy Dunbar
Co-Chair
Sharon Terry
Co-Chair
James Beck
Member
Mark Frohlich
Member
Lawrence S. Goldstein
Member
Deborah K. Hoshizaki
Member
Audrey Kusiak
Member
Cato T. Laurencin
Member
Richard McFarland
Member
Thomas Petersen
Member
Anne Plant
Member
Stephen M. Rose
Member
Krishnendu Roy
Member
Jay P. Siegel
Member
Martha Somerman
Member
Jiwen Zhang
Member
Claudia Zylberberg
Member
Sponsors
Department of Health and Human Services
Other, Federal
Private: For Profit
Private: Non Profit
Major units and sub-units
Health and Medicine Division
Lead
Board on Health Sciences Policy
Lead